Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jun;39(6):605–609.

A suggested approach to once-daily aminoglycoside dosing.

E J Begg 1, M L Barclay 1, S B Duffull 1
PMCID: PMC1365071  PMID: 7654477

Abstract

1. Once-daily aminoglycoside dosing has many advantages and has been widely advocated. However, existing guidelines for methods of administration and monitoring are non-specific and may lead to excessive dosing. 2. The traditional approach of aiming for target peak and trough concentrations is not appropriate for once-daily dosing. 3. A method is proposed which uses a target area under the concentration-time curve (AUC) for the aminoglycoside based on the 24 h AUC that would result with conventional dosing. This method requires measurement of two drug concentrations, one approximately 0.5 h after the end of the infusion and another at a later time (6-22 h) depending on renal function. 4. A simpler, graphical method is also proposed for patients with normal renal function, which requires the measurement of a single concentration at a time between 6 and 14 h. 5. Both methods are likely to be safer than existing guidelines.

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barclay M. L., Begg E. J., Hickling K. G. What is the evidence for once-daily aminoglycoside therapy? Clin Pharmacokinet. 1994 Jul;27(1):32–48. doi: 10.2165/00003088-199427010-00004. [DOI] [PubMed] [Google Scholar]
  2. Bignardi G. E., Riley U. Once-daily aminoglycoside dosing. Lancet. 1993 Apr 3;341(8849):894–895. doi: 10.1016/0140-6736(93)93103-8. [DOI] [PubMed] [Google Scholar]
  3. Burton M. E., Brater D. C., Chen P. S., Day R. B., Huber P. J., Vasko M. R. A Bayesian feedback method of aminoglycoside dosing. Clin Pharmacol Ther. 1985 Mar;37(3):349–357. doi: 10.1038/clpt.1985.51. [DOI] [PubMed] [Google Scholar]
  4. Gilbert D. N. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother. 1991 Mar;35(3):399–405. doi: 10.1128/aac.35.3.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Konrad F., Wagner R., Neumeister B., Rommel H., Georgieff M. Studies on drug monitoring in thrice and once daily treatment with aminoglycosides. Intensive Care Med. 1993;19(4):215–220. doi: 10.1007/BF01694773. [DOI] [PubMed] [Google Scholar]
  6. Moore R. D., Smith C. R., Lietman P. S. Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med. 1984 Oct;77(4):657–662. doi: 10.1016/0002-9343(84)90358-9. [DOI] [PubMed] [Google Scholar]
  7. Nicolau D., Quintiliani R., Nightingale C. H. Once-daily aminoglycosides. Conn Med. 1992 Oct;56(10):561–563. [PubMed] [Google Scholar]
  8. Parker S. E., Davey P. G. Once-daily aminoglycoside dosing. Lancet. 1993 Feb 6;341(8841):346–347. doi: 10.1016/0140-6736(93)90143-5. [DOI] [PubMed] [Google Scholar]
  9. Parker S. E., Davey P. G. Practicalities of once-daily aminoglycoside dosing. J Antimicrob Chemother. 1993 Jan;31(1):4–8. doi: 10.1093/jac/31.1.4. [DOI] [PubMed] [Google Scholar]
  10. Pesola G. R., Akhavan I., Madu A., Shah N. K., Carlon G. C. Prediction equation estimates of creatinine clearance in the intensive care unit. Intensive Care Med. 1993;19(1):39–43. doi: 10.1007/BF01709276. [DOI] [PubMed] [Google Scholar]
  11. Prins J. M., Büller H. R., Kuijper E. J., Tange R. A., Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet. 1993 Feb 6;341(8841):335–339. doi: 10.1016/0140-6736(93)90137-6. [DOI] [PubMed] [Google Scholar]
  12. Reeves D. S., MacGowan A. P. Once-daily aminoglycoside dosing. Lancet. 1993 Apr 3;341(8849):895–896. [PubMed] [Google Scholar]
  13. Sawchuk R. J., Zaske D. E., Cipolle R. J., Wargin W. A., Strate R. G. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther. 1977 Mar;21(3):362–369. doi: 10.1002/cpt1977213362. [DOI] [PubMed] [Google Scholar]
  14. ter Braak E. W., de Vries P. J., Bouter K. P., van der Vegt S. G., Dorrestein G. C., Nortier J. W., van Dijk A., Verkooyen R. P., Verbrugh H. A. Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone. Am J Med. 1990 Jul;89(1):58–66. doi: 10.1016/0002-9343(90)90099-y. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES